This explains, to some extent, the results reported by Huang et al., 2018 who found that overexpression of the ABCB4 gene in breast cancer cell lines is associated with resistance to doxorubicin and, as a consequence, may determine the tumour response to chemotherapy [48]. Here, ABCB4 is linked to neoplasm.